
Doctor Martin Huemer
Charite University Hospital, Berlin (Germany)
Follow
Contributor content
Presentation
Safety of continuous use of Apixaban, Rivaroxaban and Dabigatran in patients undergoing cardiac implantable electronic device implantation in a real-world cohort
Presentation

